Science
Influenza A+B Fluorescent Immunoassay (FIA) (Quidel Corporation, San Diego, CA) have become available. These RIDTs differ from previous visually-read rapid influenzadetection tests because results of the newer tests are analyzed and interpreted digitally, potentially increasing the sensitivity of the assay by detecting a smaller amount of antigen and reducing operator variability.
The Sofia Influenza A+B FIA is a novel fluorescence-based lateral flow immunoassay that uses specific antibodycoated beads coupled to a heat-and light-stable europium conjugate to detect Flu A and influenza B (Flu B) viral nucleoprotein antigens; this contrasts with the other assays, which are based on chromogenic or lateral-flow immunoassays. 10, 11 The Sofia Analyzer uses the europium 
Materials and Methods
During the peak of the influenza season, from mid- A viral culture or a Simplexa PCR assay was also set up, depending on which of the 2 tests had not already been performed. The viral cultures were prepared by inoculating 0.2 mL of aliquot of the specimen into an R-Mix Too respiratory shell vial (Quidel Corporation) and incubated at 35°C to 37°C, 5% CO 2 , for 48 hours. We identified Flu A virus by examining the shell vials for cytopathic effect and then used a Direct Fluorescent-Antibody (DFA) method (D3 Ultra DFA Respiratory Virus Screening and ID Kit, Quidel Corporation) to detect Flu A virus in cell cultures.
The main purpose of this study was to evaluate the sensitivity of the Sofia Influenza A + B FIA at detecting the Flu A(H1N1)pdm09 subtype using the Simplexa Flu A/B and RSV Direct real-time RT-PCR assay and virus culture results as standards.
Results
During the study period of approximately 3 months, 40 nasopharyngeal swab specimens met the criteria by testing positive for Flu A and for the subtype (H1N1)pdm09. The Simplexa PCR assay identified 37 of the specimens as having positive results for Flu A; 3 specimens were identified as testing positive for Flu A by viral culture. The 3 specimens with positive results as identified by viral culture were retrospectively tested with the Simplexa PCR assay and all 3 produced a positive result for Flu A. All 40 specimens tested positive for Flu A via the GenMark Diagnostics eSensor RVP and all were of the (H1N1)pdm09 subtype ( Table 1) . Of the 40 specimens, 27 tested positive (67.5%) by Sofia Influenza A+B FIA for Flu A ( Table 2) . Of the 13 specimens that tested negative via Sofia, 4 had a coinfection that was detected by the GenMark Diagnostics eSensor RVP, 2 had human rhinovirus, and 2 had parainfluenza virus type 1.
Cycle threshold (C T ) values ranged from 30.2 to 36.3 (mean C T , 34.4) for the 13 specimens that tested negative via Sofia on the Simplexa RT-PCR assay and from 17.6 to 34.0 (mean C T 28.1) for the 27 specimens that tested positive via Sofia (Figure 1) . The difference in the cycle threshold values between the positive and negative Sofia results was statistically significant (unpaired t test, P <.001). 
Discussion
Accurate and timely diagnosis of Flu A is crucial for clinical management, infection-control measures, and publichealth action to limit transmission of the virus. RIDTs are useful to health care professionals at the point of care. These tests are easy to perform; also, clinic staff with limited laboratory experience can perform the Clinical Laboratory Improvement Amendments of 1988 (CLIA)-waived assays. Such assays can provide results in 15 minutes, which is ideal for an acute-care or a physician-office setting in which health care professionals have limited time to examine patients.
However, the results of RIDTs are sometimes misleading; many factors can affect the performance of these tests. The accuracy of the results depends on the prevalence of Flu A in the population at the time of testing. Falsepositive Flu A test results are more likely to occur when disease prevalence is low, and false-negative Flu A test results are more likely to occur when disease prevalence is high. The viral load present in the specimen and the Flu A virus strains tested affect test results. 15, 16 The introduction of more sophisticated assays with digital analyzers, such as the Sofia and BD Veritor, has improved the sensitivity of the RIDTs by detecting the presence of viral antigens at lower concentrations and their capability to detect different circulating influenza types and strains. 5 The influenza season from 2013 through 2014 is the first season with the influenza A subtype Flu A(H1N1)pdm09 as the predominant influenza virus circulating in the United States since this subtype emerged in 2009. 17 The resurgence of (H1N1)pdm09 provided us the opportunity to evaluate the ability of 1 of the new RIDTs to detect this Flu A subtype. This study showed that the sensitivity (67.5%) of the Sofia Influenza A+B FIA in detecting Flu A(H1N1)pdm09 was comparable to previously reported sensitivities for earlier RIDTs. [6] [7] [8] The Sofia Influenza A+B FIA misidentified 2 specimens as Flu B, whereas they were identified as Flu A by the Simplexa and the GenMark Diagnostics eSensor. This raises the question of possible cross-reaction of the nucleoprotein antigens for Flu A and Flu B, which suggests decreased specificity of the assay. All 4 specimens with dual infection tested negative with the Sofia instrument, raising the possibility that coinfection may affect the ability of the assay to detect Flu A(H1N1) pdm09 or Flu A in general.
The sensitivity (67.5%) of the recently introduced Sofia Influenza A+B FIA was comparable to viral culture for the detection of Flu A, as described also by others. 12 Most of the viral cultures (37 of 40 total specimens) were set up with specimens that had been frozen, which may have increased the likelihood of negative culture results.
In one study, the Sofia had a high rate of false-positive results for Flu A and Flu B. 13 In our study, we could not verify this finding because all tested specimens were known to have tested positive for Flu A per the Simplexa Focus PCR assay. Test sensitivity improves in specimens from patients with higher nasopharyngeal viral load, as demonstrated indirectly by the Simplexa PCR assay mean cycle threshold values of 28.1 for the positive Sofia result and 34.4 for the negative result. 15, 16 The 4 pediatric specimens all tested positive for Flu A by the Sofia assay and had a high viral load, as implied by the low cycle threshold values (31.8, 31.0, 26.1, and 22.1) on the Simplexa PCR assay. 
Science
These results are consistent with previous data showing that children shed more influenza virus than adults. 9 From the presented data, the performance of the Sofia Influenza A+B FIA to detect Flu A(H1N1)pdm09 was equivalent to that of other lateral-flow immunoassays RIDTs. [6] [7] [8] 18 Our study was limited by the small number of specimens and the fact that the Sofia Influenza A+B FIA and the additional studies were performed on frozen specimens. These factors may have biased the results.
Conclusions
Based on the results of our study, it appears that the performance of the Sofia Influenza A+B FIA as a rapid influenza test to diagnose Flu A(H1N1)pdm09 at the point of care was adequate. However, healthcare professionals cannot entirely rely on Sofia Influenza A+B FIA results and should order more sensitive assays, such as real-time RT-PCR, when the clinical findings are not concordant with the Sofia results.
